Literature DB >> 11251889

Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.

V Bongertz1, C I Costa, V G Veloso, B Grinsztejn, E C João Filho, G Calvet, J H Pilotto, M L Guimarães, M G Morgado.   

Abstract

Neutralization analyses were carried out with plasma from 132 volunteer human immunodeficiency virus (HIV)-1 infected women (76% pregnant, 24% with infants suspected for HIV-1 infection) collected between 1994 and 1998, against autologous and heterologous primary- and the reference HIV-1 MN isolates. A significantly lower percentage of HIV-1 transmissions was observed after 1996, parallel to a more intense antiretroviral treatment of infected pregnant women. HIV-1 isolation was significantly more frequent from peripheral blood mononuclear cells of mothers of infected children than mothers of uninfected children (P = 0.0065). Neutralization of autologous HIV-1 isolates was comparable for HIV-1 transmitters and nontransmitters' plasma, whereas neutralization of the reference isolate HIV-1 MN was more frequent at high titers for pregnant women who did not transmit HIV to their offspring compared to pregnant women who did. Although neutralization of heterologous primary HIV-1 isolates from HIV transmitters and non transmitters by transmitter plasma occurred with similar frequency, neutralization of isolates from transmitters was much more frequent when heterologous plasma from nontransmitters were used. Macrophage-tropic heterologous HIV-1 isolates were neutralized more frequently at higher titers by plasma from nontransmitters than from transmitters. The results obtained indicate that antiretroviral treatment, lack of success of HIV-1 isolation and high titers of antibodies able to neutralize macrophage-tropic viruses appear to be of importance for protection against HIV-1 vertical transmission for the group of patients studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251889     DOI: 10.1046/j.1365-3083.2001.00866.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Short communication: neutralizing antibodies in HIV-1-infected Brazilian individuals.

Authors:  Dalziza Victalina Almeida; Mariza Gonçalvez Morgado; Fernanda Heloise Côrtes; Monick Lindermeyer Guimarães; Leila Mendonça-Lima; Jose Henrique Pilotto; Beatriz Grinsztejn; Valdiléa Gonçalves Veloso; Vera Bongertz
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-18       Impact factor: 2.205

2.  The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1.

Authors:  Antoine Chaillon; Thierry Wack; Martine Braibant; Laurent Mandelbrot; Stéphane Blanche; Josiane Warszawski; Francis Barin
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

3.  The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.

Authors:  Elizabeth S Russell; Jesse J Kwiek; Jessica Keys; Kirston Barton; Victor Mwapasa; David C Montefiori; Steven R Meshnick; Ronald Swanstrom
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission.

Authors:  Tanawan Samleerat; Suzie Thenin; Gonzague Jourdain; Nicole Ngo-Giang-Huong; Alain Moreau; Pranee Leechanachai; Jirapan Ithisuknanth; Karin Pagdi; Pornpun Wannarit; Suraphan Sangsawang; Marc Lallemant; Francis Barin; Martine Braibant
Journal:  Virology       Date:  2009-03-20       Impact factor: 3.616

5.  Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.

Authors:  Amit Kumar; Claire E P Smith; Elena E Giorgi; Joshua Eudailey; David R Martinez; Karina Yusim; Ayooluwa O Douglas; Lisa Stamper; Erin McGuire; Celia C LaBranche; David C Montefiori; Genevieve G Fouda; Feng Gao; Sallie R Permar
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

6.  Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.

Authors:  Amit Kumar; Elena E Giorgi; Joshua J Tu; David R Martinez; Joshua Eudailey; Michael Mengual; Manukumar Honnayakanahalli Marichannegowda; Russell Van Dyke; Feng Gao; Sallie R Permar
Journal:  PLoS Pathog       Date:  2021-04-02       Impact factor: 7.464

Review 7.  The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?

Authors:  Martine Braibant; Francis Barin
Journal:  Retrovirology       Date:  2013-10-07       Impact factor: 4.602

8.  Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.

Authors:  Caitlin Milligan; Maxwel M Omenda; Vrasha Chohan; Katherine Odem-Davis; Barbra A Richardson; Ruth Nduati; Julie Overbaugh
Journal:  mBio       Date:  2016-02-02       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.